Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs
Isomorphic Labs raised $5 billion in biotech’s largest private round. Who invested, how the money will be used and why clinical proof is still missing.
Isomorphic Labs raised $5 billion in biotech’s largest private round. Who invested, how the money will be used and why clinical proof is still missing.
Flagship Pioneering commits £100M to a London Origination Lab to build AI-native biotech companies, its first outside the US, with a £500M partner target.